RFM
VKTX icon

Royal Fund Management’s Viking Therapeutics VKTX Stock Holding History

Royal Fund Management’s Portfolio VKTX Stock Details VKTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$683K Sell
20,976
-22,176
-51% -$713K 0.07% 199
2025
Q4 		$1.52M Buy
+43,152
New +$1.53M 0.14% 156
2025
Q3 		– Sell
-21,376
Closed -$566K – 352
2025
Q2 		$566K Buy
21,376
+485
+2% +$12.8K 0.06% 226
2025
Q1 		$505K Sell
20,891
-23,291
-53% -$736K 0.06% 234
2024
Q4 		$1.78M Buy
44,182
+32,438
+276% +$1.85M 0.19% 138
2024
Q3 		$744K Buy
11,744
+344
+3% +$20.2K 0.05% 233
2024
Q2 		$604K Buy
+11,400
New +$747K 0.08% 226

Other funds holding VKTX

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Two Sigma Investments
Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return